221 related articles for article (PubMed ID: 34198267)
21. Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.
Jin Y; Wu Z; Li C; Zhou W; Shaw JP; Baguley BC; Liu J; Zhang W
Pharm Res; 2018 Jan; 35(1):13. PubMed ID: 29302821
[TBL] [Abstract][Full Text] [Related]
22. Surface modification of paclitaxel-loaded liposomes using d-α-tocopheryl polyethylene glycol 1000 succinate: Enhanced cellular uptake and cytotoxicity in multidrug resistant breast cancer cells.
Han SM; Baek JS; Kim MS; Hwang SJ; Cho CW
Chem Phys Lipids; 2018 Jul; 213():39-47. PubMed ID: 29550143
[TBL] [Abstract][Full Text] [Related]
23. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
24. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N
Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072
[TBL] [Abstract][Full Text] [Related]
25. Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells.
Zhang H; Liu G; Zeng X; Wu Y; Yang C; Mei L; Wang Z; Huang L
Int J Nanomedicine; 2015; 10():2461-73. PubMed ID: 25848264
[TBL] [Abstract][Full Text] [Related]
26. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
[TBL] [Abstract][Full Text] [Related]
27. Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane.
Li Z; Liu K; Sun P; Mei L; Hao T; Tian Y; Tang Z; Li L; Chen D
J Microencapsul; 2013; 30(5):432-40. PubMed ID: 23517067
[TBL] [Abstract][Full Text] [Related]
28. Development and In Vitro Evaluation of Crizotinib-Loaded Lipid-Polymer Hybrid Nanoparticles Using Box-Behnken Design in Non-small Cell Lung Cancer.
Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Arica B
AAPS PharmSciTech; 2023 Sep; 24(7):178. PubMed ID: 37658977
[TBL] [Abstract][Full Text] [Related]
29. Process optimization and in vivo performance of docetaxel loaded PHBV-TPGS therapeutic vesicles: A synergistic approach.
Vardhan H; Mittal P; Adena SKR; Upadhyay M; Yadav SK; Mishra B
Int J Biol Macromol; 2018 Mar; 108():729-743. PubMed ID: 29111267
[TBL] [Abstract][Full Text] [Related]
30. Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma.
Sharma PK; Chauhan MK
Curr Eye Res; 2021 Nov; 46(11):1703-1716. PubMed ID: 33844617
[No Abstract] [Full Text] [Related]
31. Pomegranate extract-loaded solid lipid nanoparticles: design, optimization, and in vitro cytotoxicity study.
Badawi NM; Teaima MH; El-Say KM; Attia DA; El-Nabarawi MA; Elmazar MM
Int J Nanomedicine; 2018; 13():1313-1326. PubMed ID: 29563789
[TBL] [Abstract][Full Text] [Related]
32. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
Akhter MH; Kumar S; Nomani S
Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
[No Abstract] [Full Text] [Related]
33. Effect of variables on exemestane-loaded albumin nanoparticles: statistical optimization and anti-cancer activity in MCF-7 cell lines.
Vyas D; Wairkar S
Pharm Dev Technol; 2023 Dec; 28(10):1048-1055. PubMed ID: 37987762
[TBL] [Abstract][Full Text] [Related]
34. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
[TBL] [Abstract][Full Text] [Related]
35. Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel.
Raju A; Muthu MS; Feng SS
Expert Opin Drug Deliv; 2013 Jun; 10(6):747-60. PubMed ID: 23458409
[TBL] [Abstract][Full Text] [Related]
36. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
Pan J; Feng SS
Biomaterials; 2008 Jun; 29(17):2663-72. PubMed ID: 18396333
[TBL] [Abstract][Full Text] [Related]
37. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors.
Rizwanullah M; Alam M; Harshita ; Mir SR; Rizvi MMA; Amin S
Curr Pharm Des; 2020; 26(11):1206-1215. PubMed ID: 31951163
[TBL] [Abstract][Full Text] [Related]
38. Development and optimization of TPGS-based stealth liposome of doxorubicin using Box-Behnken design: characterization, hemocompatibility, and cytotoxicity evaluation in breast cancer cells.
Kurmi BD; Paliwal SR
J Liposome Res; 2022 Jun; 32(2):129-145. PubMed ID: 33724151
[TBL] [Abstract][Full Text] [Related]
39. Fabrication of TPGS-Stabilized Liposome-PLGA Hybrid Nanoparticle Via a New Modified Nanoprecipitation Approach: In Vitro and In Vivo Evaluation.
Zhang M; He J; Zhang W; Liu J
Pharm Res; 2018 Aug; 35(11):199. PubMed ID: 30167890
[TBL] [Abstract][Full Text] [Related]
40. Pterostilbene nanoparticles with small particle size show excellent anti-breast cancer activity
Zou Y; Wang X; Bi D; Fu J; Han J; Guo Y; Feng L; Han M
Nanotechnology; 2021 May; 32(32):. PubMed ID: 33946061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
